Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Structure-function guided modeling of chemokine-GPCR specificity for the chemokine XCL1 and its receptor XCR1.

Fox JC, Thomas MA, Dishman AF, Larsen O, Nakayama T, Yoshie O, Rosenkilde MM, Volkman BF.

Sci Signal. 2019 Sep 3;12(597). pii: eaat4128. doi: 10.1126/scisignal.aat4128.

PMID:
31481523
2.

Strong optical absorption of a metallic film to induce a lensing effect in the visible region.

Jiang AQ, Zang KY, Hu ET, Tu HT, Xu L, Ren WS, Yoshie O, Lee YP, Zheng YX, Wang SY, Zhao HB, Guo JP, Wang CZ, Ho KM, Lynch DW, Chen LY.

Sci Rep. 2019 Aug 27;9(1):12434. doi: 10.1038/s41598-019-48938-z.

3.

Ultrahigh-resolution spectrometer based on 19 integrated gratings.

Jiang AQ, Zang KY, Tu HT, Chen JK, Lu WJ, Yoshie O, Wang XP, Xiang XD, Lee YP, Chen B, Zheng YX, Wang SY, Zhao HB, Yang YM, Chen LY.

Sci Rep. 2019 Jul 15;9(1):10211. doi: 10.1038/s41598-019-46792-7.

4.

Epstein-Barr virus-positive pyothorax-associated lymphoma expresses CCL17 and CCL22 chemokines that attract CCR4-expressing regulatory T cells.

Higuchi T, Matsuo K, Hashida Y, Kitahata K, Ujihara T, Taniguchi A, Yoshie O, Nakayama T, Daibata M.

Cancer Lett. 2019 Jul 1;453:184-192. doi: 10.1016/j.canlet.2019.03.053. Epub 2019 Apr 3.

PMID:
30953706
5.

Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery.

Ito M, Komai K, Mise-Omata S, Iizuka-Koga M, Noguchi Y, Kondo T, Sakai R, Matsuo K, Nakayama T, Yoshie O, Nakatsukasa H, Chikuma S, Shichita T, Yoshimura A.

Nature. 2019 Jan;565(7738):246-250. doi: 10.1038/s41586-018-0824-5. Epub 2019 Jan 2.

PMID:
30602786
6.

A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8+ T Cells.

Matsuo K, Kitahata K, Kawabata F, Kamei M, Hara Y, Takamura S, Oiso N, Kawada A, Yoshie O, Nakayama T.

Front Immunol. 2018 Nov 27;9:2775. doi: 10.3389/fimmu.2018.02775. eCollection 2018.

7.

Heat shock protein 27 promotes cell cycle progression by down-regulating E2F transcription factor 4 and retinoblastoma family protein p130.

Park AM, Tsunoda I, Yoshie O.

J Biol Chem. 2018 Oct 12;293(41):15815-15826. doi: 10.1074/jbc.RA118.003310. Epub 2018 Aug 30.

PMID:
30166342
8.

A High-Performance Spectrometer with Two Spectral Channels Sharing the Same BSI-CMOS Detector.

Zang KY, Yao Y, Hu ET, Jiang AQ, Zheng YX, Wang SY, Zhao HB, Yang YM, Yoshie O, Lee YP, Lynch DW, Chen LY.

Sci Rep. 2018 Aug 23;8(1):12660. doi: 10.1038/s41598-018-31124-y.

9.

A CCR4 antagonist enhances DC activation and homing to the regional lymph node and shows potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment.

Yamamoto S, Matsuo K, Nagakubo D, Higashiyama S, Nishiwaki K, Oiso N, Kawada A, Yoshie O, Nakayama T.

J Pharmacol Sci. 2018 Mar;136(3):165-171. doi: 10.1016/j.jphs.2018.02.001. Epub 2018 Feb 8.

10.

CCR4 Is Critically Involved in Skin Allergic Inflammation of BALB/c Mice.

Matsuo K, Nagakubo D, Komori Y, Fujisato S, Takeda N, Kitamatsu M, Nishiwaki K, Quan YS, Kamiyama F, Oiso N, Kawada A, Yoshie O, Nakayama T.

J Invest Dermatol. 2018 Aug;138(8):1764-1773. doi: 10.1016/j.jid.2018.02.027. Epub 2018 Mar 3.

11.

Murine γ-Herpesvirus 68 Induces Severe Lung Inflammation in IL-27-Deficient Mice with Liver Dysfunction Preventable by Oral Neomycin.

Kanai K, Park AM, Watanabe A, Arikawa T, Yasui T, Yoshida H, Tsunoda I, Yoshie O.

J Immunol. 2018 Apr 15;200(8):2703-2713. doi: 10.4049/jimmunol.1700412. Epub 2018 Mar 2.

12.

CCL28-Deficient Mice Have Reduced IgA Antibody-Secreting Cells and an Altered Microbiota in the Colon.

Matsuo K, Nagakubo D, Yamamoto S, Shigeta A, Tomida S, Fujita M, Hirata T, Tsunoda I, Nakayama T, Yoshie O.

J Immunol. 2018 Jan 15;200(2):800-809. doi: 10.4049/jimmunol.1700037. Epub 2017 Dec 13.

13.

High photon-to-heat conversion efficiency in the wavelength region of 250-1200 nm based on a thermoelectric Bi2Te3 film structure.

Hu ET, Yao Y, Zang KY, Liu XX, Jiang AQ, Zheng JJ, Yu KH, Wei W, Zheng YX, Zhang RJ, Wang SY, Zhao HB, Yoshie O, Lee YP, Wang CZ, Lynch DW, Guo JP, Chen LY.

Sci Rep. 2017 Mar 16;7:44614. doi: 10.1038/srep44614.

14.

Renal infarct volume and renal function decline in acute and chronic phases.

Kagaya S, Yoshie O, Fukami H, Sato H, Saito A, Takeuchi Y, Matsuda K, Nagasawa T.

Clin Exp Nephrol. 2017 Dec;21(6):1030-1034. doi: 10.1007/s10157-017-1399-4. Epub 2017 Mar 10.

PMID:
28283850
15.

Translational Repression of a Splice Variant of Cynomolgus Macaque CXCL1L by Its C-Terminal Sequence.

Nomiyama H, Osada N, Takahashi I, Terao K, Yamagata K, Yoshie O.

J Interferon Cytokine Res. 2017 Mar;37(3):129-138. doi: 10.1089/jir.2016.0085. Epub 2017 Feb 10.

PMID:
28186423
16.

IL-35 Suppresses Lipopolysaccharide-Induced Airway Eosinophilia in EBI3-Deficient Mice.

Kanai K, Park AM, Yoshida H, Tsunoda I, Yoshie O.

J Immunol. 2017 Jan 1;198(1):119-127. Epub 2016 Nov 23.

17.

Neolignans from the Arils of Myristica fragrans as Potent Antagonists of CC Chemokine Receptor 3.

Morikawa T, Hachiman I, Matsuo K, Nishida E, Ninomiya K, Hayakawa T, Yoshie O, Muraoka O, Nakayama T.

J Nat Prod. 2016 Aug 26;79(8):2005-13. doi: 10.1021/acs.jnatprod.6b00262. Epub 2016 Jul 15.

PMID:
27419473
18.

Efficient Use of a Crude Drug/Herb Library Reveals Ephedra Herb As a Specific Antagonist for TH2-Specific Chemokine Receptors CCR3, CCR4, and CCR8.

Matsuo K, Koizumi K, Fujita M, Morikawa T, Jo M, Shibahara N, Saiki I, Yoshie O, Nakayama T.

Front Cell Dev Biol. 2016 Jun 7;4:54. doi: 10.3389/fcell.2016.00054. eCollection 2016.

19.

CCR4 is critically involved in effective antitumor immunity in mice bearing intradermal B16 melanoma.

Matsuo K, Itoh T, Koyama A, Imamura R, Kawai S, Nishiwaki K, Oiso N, Kawada A, Yoshie O, Nakayama T.

Cancer Lett. 2016 Aug 1;378(1):16-22. doi: 10.1016/j.canlet.2016.04.039. Epub 2016 Apr 28.

PMID:
27132989
20.

Upregulated CCL28 expression in the nasal mucosa in experimental allergic rhinitis: Implication for CD4(+) memory T cell recruitment.

Nagakubo D, Yoshie O, Hirata T.

Cell Immunol. 2016 Apr;302:58-62. doi: 10.1016/j.cellimm.2016.02.001. Epub 2016 Feb 2.

PMID:
26868716
21.

Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis.

Park AM, Kanai K, Itoh T, Sato T, Tsukui T, Inagaki Y, Selman M, Matsushima K, Yoshie O.

PLoS One. 2016 Feb 9;11(2):e0148998. doi: 10.1371/journal.pone.0148998. eCollection 2016.

22.

Galectin-3 Plays an Important Role in Innate Immunity to Gastric Infection by Helicobacter pylori.

Park AM, Hagiwara S, Hsu DK, Liu FT, Yoshie O.

Infect Immun. 2016 Mar 24;84(4):1184-1193. doi: 10.1128/IAI.01299-15. Print 2016 Apr.

23.

C-C chemokine receptor type 4 antagonist Compound 22 ameliorates experimental autoimmune encephalomyelitis.

Moriguchi K, Miyamoto K, Tanaka N, Ueno R, Nakayama T, Yoshie O, Kusunoki S.

J Neuroimmunol. 2016 Feb 15;291:54-8. doi: 10.1016/j.jneuroim.2015.12.011. Epub 2015 Dec 24.

PMID:
26857495
24.

Role of chemokine CX3CL1 in progression of multiple myeloma via CX3CR1 in bone microenvironments.

Wada A, Ito A, Iitsuka H, Tsuneyama K, Miyazono T, Murakami J, Shibahara N, Sakurai H, Saiki I, Nakayama T, Yoshie O, Koizumi K, Sugiyama T.

Oncol Rep. 2015 Jun;33(6):2935-9. doi: 10.3892/or.2015.3941. Epub 2015 Apr 28.

PMID:
25962684
25.

High efficiency of photon-to-heat conversion with a 6-layered metal/dielectric film structure in the 250-1200 nm wavelength region.

Liu MH, Hu ET, Yao Y, Zang KY, He N, Li J, Zheng YX, Wang SY, Yoshie O, Lee Y, Wang CZ, Lynch DW, Chen LY.

Opt Express. 2014 Dec 15;22 Suppl 7:A1843-52. doi: 10.1364/OE.22.0A1843.

PMID:
25607498
26.

Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily.

Fox JC, Nakayama T, Tyler RC, Sander TL, Yoshie O, Volkman BF.

Cytokine. 2015 Feb;71(2):302-11. doi: 10.1016/j.cyto.2014.11.010. Epub 2014 Dec 11.

27.

CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages.

Kee JY, Ito A, Hojo S, Hashimoto I, Igarashi Y, Tsuneyama K, Tsukada K, Irimura T, Shibahara N, Takasaki I, Inujima A, Nakayama T, Yoshie O, Sakurai H, Saiki I, Koizumi K.

BMC Cancer. 2014 Dec 15;14:949. doi: 10.1186/1471-2407-14-949.

28.

Functional roles of evolutionary conserved motifs and residues in vertebrate chemokine receptors.

Nomiyama H, Yoshie O.

J Leukoc Biol. 2015 Jan;97(1):39-47. doi: 10.1189/jlb.2RU0614-290R. Epub 2014 Nov 21.

PMID:
25416815
29.

Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia/lymphoma patient.

Taguchi M, Imaizumi Y, Sasaki D, Higuchi T, Tsuruda K, Hasegawa H, Taguchi J, Sawayama Y, Imanishi D, Hata T, Yanagihara K, Yoshie O, Miyazaki Y.

Ann Hematol. 2015 Apr;94(4):693-5. doi: 10.1007/s00277-014-2239-1. Epub 2014 Oct 23. No abstract available.

PMID:
25338968
30.

A pleomorphic carcinoma of the lung producing multiple cytokines and forming a rapidly progressive mass-like opacity.

Matsumoto M, Nakayama T, Inoue D, Takamatsu K, Itotani R, Ishitoko M, Suzuki S, Sakuramoto M, Yuba Y, Yoshie O, Takemura M, Fukui M.

BMC Cancer. 2014 Aug 13;14:588. doi: 10.1186/1471-2407-14-588.

31.

CCR4 and its ligands: from bench to bedside.

Yoshie O, Matsushima K.

Int Immunol. 2015 Jan;27(1):11-20. doi: 10.1093/intimm/dxu079. Epub 2014 Aug 2. Review.

PMID:
25087232
32.

Generation of colonic IgA-secreting cells in the caecal patch.

Masahata K, Umemoto E, Kayama H, Kotani M, Nakamura S, Kurakawa T, Kikuta J, Gotoh K, Motooka D, Sato S, Higuchi T, Baba Y, Kurosaki T, Kinoshita M, Shimada Y, Kimura T, Okumura R, Takeda A, Tajima M, Yoshie O, Fukuzawa M, Kiyono H, Fagarasan S, Iida T, Ishii M, Takeda K.

Nat Commun. 2014 Apr 10;5:3704. doi: 10.1038/ncomms4704.

PMID:
24718324
33.

[Chemokines and allergy].

Yoshie O.

Arerugi. 2013 Aug;62(8):911-23. Review. Japanese. No abstract available.

PMID:
24335417
34.

International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, Horuk R, Sparre-Ulrich AH, Locati M, Luster AD, Mantovani A, Matsushima K, Murphy PM, Nibbs R, Nomiyama H, Power CA, Proudfoot AE, Rosenkilde MM, Rot A, Sozzani S, Thelen M, Yoshie O, Zlotnik A.

Pharmacol Rev. 2013 Nov 11;66(1):1-79. doi: 10.1124/pr.113.007724. Print 2014. Review. Erratum in: Pharmacol Rev. 2014 Apr;66(2):467.

35.

Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer.

Zhao L, Yasumoto K, Kawashima A, Nakagawa T, Takeuchi S, Yamada T, Matsumoto K, Yonekura K, Yoshie O, Yano S.

Cancer Sci. 2013 Dec;104(12):1640-6. doi: 10.1111/cas.12301. Epub 2013 Nov 13.

36.

Chemokine receptors as therapeutic targets.

Yoshie O.

Nihon Rinsho Meneki Gakkai Kaishi. 2013;36(4):189-96. Review. English, Japanese.

PMID:
23994796
37.

Genome diversification mechanism of rodent and Lagomorpha chemokine genes.

Shibata K, Nomiyama H, Yoshie O, Tanase S.

Biomed Res Int. 2013;2013:856265. doi: 10.1155/2013/856265. Epub 2013 Aug 7.

38.

[Chemokines and chemokine receptors].

Yoshie O.

Nihon Rinsho. 2012 Nov;70 Suppl 8:212-7. Japanese. No abstract available.

PMID:
23513839
39.

SOX4 is a direct target gene of FRA-2 and induces expression of HDAC8 in adult T-cell leukemia/lymphoma.

Higuchi T, Nakayama T, Arao T, Nishio K, Yoshie O.

Blood. 2013 May 2;121(18):3640-9. doi: 10.1182/blood-2012-07-441022. Epub 2013 Mar 12.

PMID:
23482931
40.

The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis.

Moriguchi K, Miyamoto K, Tanaka N, Yoshie O, Kusunoki S.

J Neuroimmunol. 2013 Apr 15;257(1-2):53-8. doi: 10.1016/j.jneuroim.2013.02.002. Epub 2013 Mar 7.

PMID:
23477966
41.

Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model.

Kee JY, Ito A, Hojo S, Hashimoto I, Igarashi Y, Tsukada K, Irimura T, Shibahara N, Nakayama T, Yoshie O, Sakurai H, Saiki I, Koizumi K.

Oncol Rep. 2013 Mar;29(3):975-82. doi: 10.3892/or.2012.2185. Epub 2012 Dec 13.

PMID:
23242131
42.

Systematic classification of vertebrate chemokines based on conserved synteny and evolutionary history.

Nomiyama H, Osada N, Yoshie O.

Genes Cells. 2013 Jan;18(1):1-16. doi: 10.1111/gtc.12013. Epub 2012 Nov 12. Review.

43.

The chemokine superfamily revisited.

Zlotnik A, Yoshie O.

Immunity. 2012 May 25;36(5):705-16. doi: 10.1016/j.immuni.2012.05.008. Review.

44.

Expression and function of FRA2/JUND in cutaneous T-cell lymphomas.

Nakayama T, Higuchi T, Oiso N, Kawada A, Yoshie O.

Anticancer Res. 2012 Apr;32(4):1367-73.

PMID:
22493372
45.

Selective down-regulation of Th2 cell-mediated airway inflammation in mice by pharmacological intervention of CCR4.

Kaminuma O, Ohtomo T, Mori A, Nagakubo D, Hieshima K, Ohmachi Y, Noda Y, Katayama K, Suzuki K, Motoi Y, Kitamura N, Saeki M, Nishimura T, Yoshie O, Hiroi T.

Clin Exp Allergy. 2012 Feb;42(2):315-25. doi: 10.1111/j.1365-2222.2011.03847.x. Epub 2011 Sep 1.

PMID:
22092376
46.

In situ expression of the CCL20-CCR6 axis in lymphocyte-rich gastric cancer and its potential role in the formation of lymphoid stroma.

Ohtani H, Nakayama T, Yoshie O.

Pathol Int. 2011 Nov;61(11):645-51. doi: 10.1111/j.1440-1827.2011.02717.x. Epub 2011 Sep 16.

PMID:
22029675
47.

A family tree of vertebrate chemokine receptors for a unified nomenclature.

Nomiyama H, Osada N, Yoshie O.

Dev Comp Immunol. 2011 Jul;35(7):705-15. doi: 10.1016/j.dci.2011.01.019. Epub 2011 Feb 2. Review.

PMID:
21295066
48.

c-Maf suppresses human T-cell leukemia virus type 1 Tax by competing for CREB-binding protein.

Hieshima K, Nagakubo D, Shigeta A, Tanaka Y, Hoshino H, Tsukasaki K, Yamada Y, Yoshie O.

Cancer Sci. 2011 Apr;102(4):890-4. doi: 10.1111/j.1349-7006.2011.01873.x. Epub 2011 Feb 15.

49.

Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1.

Nakayama T, Watanabe Y, Oiso N, Higuchi T, Shigeta A, Mizuguchi N, Katou F, Hashimoto K, Kawada A, Yoshie O.

J Immunol. 2010 Dec 1;185(11):6472-9. doi: 10.4049/jimmunol.0904126. Epub 2010 Oct 25.

50.

T cell treatment with small interfering RNA for suppressor of cytokine signaling 3 modulates allergic airway responses in a murine model of asthma.

Moriwaki A, Inoue H, Nakano T, Matsunaga Y, Matsuno Y, Matsumoto T, Fukuyama S, Kan-O K, Matsumoto K, Tsuda-Eguchi M, Nagakubo D, Yoshie O, Yoshimura A, Kubo M, Nakanishi Y.

Am J Respir Cell Mol Biol. 2011 Apr;44(4):448-55. doi: 10.1165/rcmb.2009-0051OC. Epub 2010 May 27.

PMID:
20508071

Supplemental Content

Loading ...
Support Center